Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | RDY | SUPN | ||
| Company | Cymabay Therapeutics | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 32.49 | 12.85 | 46.81 | ||
| High | 32.50 | 12.95 | 47.74 | ||
| Low | 32.48 | 12.75 | 46.20 | ||
| Latest | 32.48 | 12.77 | 47.73 | ||
| Change | +0.01 | -0.07 | +1.07 | ||
| % Change | +0.03% | -0.55% | +2.29% | ||
| Volume | 8,356,200 | 1,867,300 | 500,500 | ||
| 20-Day Average Volume | 3,390,805 | 3,205,795 | 999,400 | ||
| Previous Close | 32.47 | 12.84 | 46.66 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 13.98 | 46.53 | ||
| 20-Day Raw Stochastic | 94.12% | 2.36% | 59.19% | ||
| 20-Day Relative Strength | 78.00 | 40.15 | 52.13 | ||
| Weighted Alpha | +247.60 | -14.06 | +30.92 | ||
| Today's Opinion | 100% Buy | 56% Sell | 40% Sell | ||
| Previous Opinion | 100% Buy | 56% Sell | 56% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | -9.56% since 07/08/26 | -5.37% since 07/08/26 | ||
| Low | 32.44 on 03/15/24 | 12.70 on 07/14/26 | 46.09 on 07/14/26 | ||
| High | 32.50 on 03/21/24 | 14.06 on 07/09/26 | 51.37 on 07/09/26 | ||
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | -4.20% since 06/15/26 | +8.82% since 06/15/26 | ||
| Low | 32.15 on 02/22/24 | 12.70 on 07/14/26 | 42.45 on 06/16/26 | ||
| High | 32.50 on 03/21/24 | 15.67 on 06/26/26 | 51.37 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | -1.31% since 04/15/26 | -4.43% since 04/15/26 | ||
| Low | 22.11 on 01/26/24 | 12.19 on 05/12/26 | 42.45 on 06/16/26 | ||
| High | 32.50 on 03/21/24 | 15.67 on 06/26/26 | 52.96 on 05/06/26 | ||
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | -2.44% since 01/15/26 | -5.03% since 01/15/26 | ||
| Low | 12.32 on 10/13/23 | 12.19 on 05/12/26 | 42.45 on 06/16/26 | ||
| High | 32.50 on 03/21/24 | 15.67 on 06/26/26 | 59.68 on 02/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 10,717,124 | 2,708,147 | ||
| Shares Outstanding, K | 114,724 | 834,667 | 58,040 | ||
| Annual Sales | 31,070,000 | 3,580,000,000 | 718,950,000 | ||
| Annual Net Income | -105,370,000 | 456,000,000 | -38,550,000 | ||
| Last Quarter Sales | 60,000 | 593,010,000 | 207,710,000 | ||
| Last Quarter Net Income | -41,900,000 | -10,780,000 | -2,290,000 | ||
| 60-Month Beta | 0.32 | 0.25 | 0.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | 0.06 on 05/12/26 | 0.59 on 05/05/26 | ||
| Earnings Date | 05/20/24 | 07/22/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | 0.071 on 07/25/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 07/24/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.18 | 19.41 | ||